Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts
Irene Braña(Vall d'Hebron Institute of Oncology), Ming‐Sound Tsao(Kumamoto University)
Cited by 39
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|479
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
|New England Journal of Medicine|2025|277